RxDoctor Payments Data

Alicia King

Neuromusculoskeletal Medicine & OMM · Sikeston, MONPI 1255884359

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.7% of the total across 311 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 46 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations.

$6,667in general payments, 2019–2025

Across 311 payments — averaging $21.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Amgen$998
  • Lilly USA, LLC$641
  • Eisai Inc.$602
  • AstraZeneca$237
  • Phathom Pharmaceuticals, Inc.$175
  • plus $3K from 40 others

What the payments were for

  • Food & beverage$6,647100%
  • Education$200%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few neuromusculoskeletal medicine & omm providers in Missourito place this figure against a meaningful peer group, so we don't.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide67$73,624
VraylarCariprazine Hcl18$37,884
Trelegy ElliptaFluticasone/Umeclidin/Vilanter43$31,697
FarxigaDapagliflozin Propanediol24$27,378
XareltoRivaroxaban30$25,445
JardianceEmpagliflozin26$21,926
CaplytaLumateperone Tosylate11$20,080
RexultiBrexpiprazole12$19,286
CreonLipase/Protease/Amylase11$16,260
Buprenorphine48$15,655
GemtesaVibegron12$15,532
EliquisApixaban16$14,582
SymbicortBudesonide/Formoterol Fumarate53$14,076
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen416$14,026
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$12,837

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$171$73,62467 claims
AstraZenecaFarxiga, Symbicort, Breztri Aerosphere$237$54,29295 claims
AbbVieVraylar, Creon$1,443$54,14429 claims
GSKTrelegy Ellipta$12$31,69743 claims
Boehringer IngelheimJardiance$117$21,92626 claims
PfizerEliquis, Premarin$48$20,29232 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$40$20,08011 claims
Otsuka America Pharmaceutical, Inc.Rexulti$122$19,28612 claims
Sumitomo Pharma America, Inc.Gemtesa$103$15,53212 claims
Lilly USA, LLCTrulicity$641$11,79712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few neuromusculoskeletal medicine & omm providers in Missourion file to place this against a meaningful peer group, so we don't.

Other neuromusculoskeletal medicine & omm in Sikeston

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →